Dear All:
The practice of recording Research & Development Notebook at the official format will be adopted among all scientists involving the RD process.
Paolo also provided the three postdoc fellow’s name in Bicocca participating the Istaroxime follow-on compound project.
All of those fellow follow the same practice as well to protect the CVie’s IP and trade secret.
“the names of the three postdoctoral chemists are (name and surname):
ALBERTO MINOTTI and ANDREA LURAGHI (involved in chemical synthesis)
JACOPO VERTEMARA (involved in molecular modelling).”
Dear Wed:
Do we need to collect more personal profile and CV-like information for fulfilling the RD management in IPO aspects?
Please let me know if you have any suggestions.